1. A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer. (26th February 2015) Authors: Sivalingam, Vanitha; McVey, Rhona; Gilmour, Kyle; Ali, Saad; Roberts, Chris; Renehan, Andrew; Kitchener, Henry; Crosbie, Emma Journal: Lancet Issue: Volume 385(2015)Supplement 1 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A systems biology approach to understanding the function of 5T4 oncofetal glycoprotein in ovarian cancer and the preclinical effectiveness of a 5T4 antibody drug conjugate. (23rd February 2017) Authors: Wan, Y Louise; Stevens, Adam; Hampson, Lynne; Kitchener, Henry; Stern, Peter Journal: Lancet Issue: Volume 389(2017)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Issue 9990 (18th July 2015) Authors: Kehoe, Sean; Hook, Jane; Nankivell, Matthew; Jayson, Gordon C; Kitchener, Henry; Lopes, Tito; Luesley, David; Perren, Timothy; Bannoo, Selina; Mascarenhas, Monica; Dobbs, Stephen; Essapen, Sharadah; Twigg, Jeremy; Herod, Jonathan; McCluggage, Glenn; Parmar, Mahesh; Swart, Ann-Marie Journal: Lancet Issue: Volume 386:Issue 9990(2015) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗